SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-107537
Filing Date
2021-08-19
Accepted
2021-08-19 08:00:20
Documents
12
Period of Report
2021-08-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2125470d1_8k.htm   iXBRL 8-K 33959
  Complete submission text file 0001104659-21-107537.txt   206632

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nbse-20210818.xsd EX-101.SCH 3185
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbse-20210818_lab.xml EX-101.LAB 34593
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbse-20210818_pre.xml EX-101.PRE 22710
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2125470d1_8k_htm.xml XML 3505
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 211188448
SIC: 2834 Pharmaceutical Preparations